European Healthtech startup funding raised during Q1 2014.
In Q1 2014, 30 European Healthtech companies raised a combined €158M across 30 funding rounds, up 152.5% versus Q1 2013. Switzerland led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| NovImmune | Series D+ | Feb 2014 | €49M |
| uTest_Vamsi | Series D+ | Jan 2014 | €31M |
| InDex Pharmaceuticals | Other | Feb 2014 | €18M |
| AC Immune | Series D+ |
| Jan 2014 |
| €18M |
| OrCam | Growth/Late | Mar 2014 | €11M |
| Mendor | Growth/Late | Jan 2014 | €4.7M |
| TytoCare | Series A | Mar 2014 | €4.3M |
| Gamida Cell | Growth/Late | Jan 2014 | €3.0M |
| Doctor At Work | Early VC | Mar 2014 | €2.2M |
| Medigo | Seed | Mar 2014 | €2.1M |
| Cellply | Seed | Mar 2014 | €2.0M |
| X-BOLT Orthapaedics | Seed | Jan 2014 | €1.8M |
| myTomorrows | Early VC | Feb 2014 | €1.6M |
| Simris Alg | Seed | Jan 2014 | €1.5M |
| Integrated Optics | Other | Jan 2014 | €1.2M |
